5/4/2020
As China stumbles, India plans big exports push in bulk drugs - The Economic Times
Search for News, Stock Quotes & NAV's
Business News › News › Economy › Foreign Trade
Benchmarks
NSE Gainer-Large Cap
Nifty
Biocon
364.30
9,412.10
LIVE
-447.80
10.35
FEATURED FUNDS
Mirae Asset Large Cap Fund
Regular- Growth
★★★★★
5Y RETURN
7.07 %
INVEST NOW
Stock Analysis, IPO, Mutual
Funds, Bonds & More
Market Watch
As China stumbles, India plans big exports push in bulk
drugs
Post a Comment
BY TEENA THACKER, ET BUREAU | UPDATED: MAY 01, 2020, 02.58 PM IST
NEW DELHI: The government is mulling fiscal incentive and capital subsidy for reviving
and restarting old active pharmaceutical ingredient units in a bid to make India an
alternative hub for bulk drugs at a time when China faces quality as well as trust issues.
“China today controls 55% of API space in the world. With China facing quality issues,
India can take a lead and plan big for exports,” a senior government official told ET. The
government is also looking to chart strategies to turn the country into a major exporter of
medical textiles, furniture, electronics, and toys, among other products, in the next six
months, officials said.
The commerce and industry ministry had on Wednesday held a video-conference with
industry experts of various sectors, asking them to draw up plans to take over areas
where China has vacated space, they said.
RELATED COMPANIES
EXPAND
APIs
Big Change:
The end of Five-Year Plans: All you need to know
While the Cabinet had last month approved a ₹10,000-crore incentive-based scheme to boost domestic manufacturing of APIs — a key
raw materials for drug manufacturers — by setting up bulk drug parks, industry insiders said reviving old units is the only solution to
boost production in the short term. “I firmly believe that there is no dearth of talent, entrepreneurial spirit, technology, automation and
other ingredients of manufacturing API, including intermediates, in India,” said Dinesh Dua, chairman of Pharmaceutical Export
Promotion Council (Pharmexcil) that functions under the commerce and industry ministry.
He said old existing API entrepreneurs “can be motivated through fiscal incentives in terms of capital subsidy, capex, with two years
moratorium and three years interest-free EMIs”.
https://economictimes.indiatimes.com/news/economy/foreign-trade/as-china-stumbles-india-plans-big-exports-push-in-bulk-drugs/printarticle/7548053…
1/2
5/4/2020
As China stumbles, India plans big exports push in bulk drugs - The Economic Times
“In addition, as already announced by the government of India, incremental incentive may be provided for all 53 KSMs (key starting
material, which are building blocks for APIs) and APIs for which we are vulnerably dependent on imports,” Dua said.
Know more
Recommended By Colombia
To attain self-sufficiency in bulk drugs, reduce dependence on China, and expand its market to other countries, the government is
contemplating ways to encourage domestic manufacturing of APIs by creating suitable ecosystem in the country with focus on fiscal and
procedural support to pharma companies to kick-start production of intermediates.
It has been mulling build API production capacity for the 58 APIs on which India is significantly dependent on China.
Other than pharma, medical textiles, furniture, electronics, and toys are some sectors where the government is deliberating to take
centre stage, in the next six months. Industry say that India has been dragging its feet for far too long. “India also set out to encourage
local manufacturing of bulk drugs (active pharmaceutical ingredients, or APIs) by declaring 2015 as the Year of APIs, but there has been
little progress on the ground,” said one of the pharma experts, on condition of anonymity.
Meanwhile, Bangladesh in May 2018 announced a corporate tax holiday for API and laboratory reagent manufacturers till 2032.
(This story has not been edited by economictimes.com and is auto–generated from a syndicated feed we subscribe to.)
Stay on top of business news with The Economic Times App. Download it Now!
https://economictimes.indiatimes.com/news/economy/foreign-trade/as-china-stumbles-india-plans-big-exports-push-in-bulk-drugs/printarticle/7548053…
2/2